Clinical trial Recruiting at 1 site Interventional Ages 18 and up

NIBP Accuracy Validation in Adults

Official title: Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations

Run by GE Healthcare · NCT07697950 · Data updated 2026-11-12

This study tests how accurately a non-invasive blood pressure device measures blood pressure in adults by comparing it with arterial line readings.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment130 (estimated)
SponsorGE Healthcare
Industry-sponsored
Locations1 site (Helsinki)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedJuly 13, 2026
Trial IDNCT07697950 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older who have an arterial line and cuff-fit appropriate limbs, and can consent and remain in the unit for the procedure.

Probably not a fit

Patients without an arterial line or unsuitable cuff fit, or those who do not meet other inclusion criteria, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study collects non-invasive blood pressure data alongside invasive aortic pressure measurements to validate NIBP measurement algorithms. It follows IEC 80601-2-30:2018 and ISO 81060-2:2018+AMD2:2024 standards for clinical validation. Eligible participants are adults with suitable cuff sizes and an arterial line in place, excluding those with certain conditions or previous participation. Data will be gathered in a hospital setting to assess accuracy and performance of the NIBP standard parameter module. Lead sponsor is GE Healthcare, with the study conducted at Tower Hospital and the Heart and Lung Center in Helsinki.

Why it matters

Potential benefit: If successful, the study could improve confidence in cuff-based blood pressure measurements and support deployment of more accurate NIBP devices.

How similar studies have gone: Previous validation studies have demonstrated feasibility of validating NIBP devices against invasive measurements, though results may vary by device and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age requirement: 18 and over.
2. Have an upper limb (right OR left side) that fits the cuff size of the device (circumference ranging 17 cm to 40 cm) OR have a thigh (right OR left side) that fits a cuff size of the device (circumference ranging 38 to 50 cm).
3. Have an arterial line as a standard of care, which measures blood pressure at the aortic root.
4. Able to provide written informed consent.
5. Expected to remain in the unit for the duration of the study procedure.

Exclusion Criteria:

1. Have previously participated in this study (no subject may participate more than once).
2. Pregnant and lactating women per site standard of care.
3. Subjects with peripheral arterial diseases (causing left/right arm difference)
4. Hemodynamically unstable subjects at the discretion of the investigator.
5. Exhibited injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the Investigator, may prevent proper cuff application or functioning.
6. Are suffering from infection(s) or immunocompromised patients that require isolation.
7. PI or designee decision due to subject health conditions

Where it's running

  • Tower Hospital, the Heart and Lung Center
    Helsinki, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.